Medtronic (NYSE:MDT) today announced a slew of developments from its diabetes treatment arm, including FDA clearance of its MiniMed Connect diabetes monitoring system; a partnership with Samsung Electronics (LON:BC94) to develop technology for diabetes management; and an agreement with diabetes-monitoring platform developer Glooko. The announcements were made at the American Diabetes Assn.’s annual meeting in Boston. […]
The post Diabetes: Medtronic partners with Samsung, Glooko; wins 510(k) for MiniMed Connect appeared first on MassDevice.
from MassDevice http://ift.tt/1KR3ZI6
Cap comentari:
Publica un comentari a l'entrada